10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

Endpoints News#ASCO26: Personalized cancer vaccines may help brain cancer patients live longer

Endpoints News#ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts say

FierceBiotechIn next-gen IO race in NSCLC, BioNTech/BMS and Pfizer are divided on overall survival approach

IlluminaIllumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance Singapore

CellDecoding the spatiotemporal development of human meninges

CellFronto-insular circuit mechanisms of accelerated intermittent theta burst stimulation

CellPhysiological brain clearance architecture revealed by neuronal protein tracing

FierceBiotechASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’

Endpoints NewsCan AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and more

AgilentMettler-Toledo International vs Agilent Technologies: Which Is the Stronger Buy Today? - Trefis

IlluminaIllumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360

BioPharma DiveAt ASCO, Merck makes case for a ‘cornerstone’ cancer drug